Lombard Odier Asset Management (Switzerland)’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-34,007
Closed -$14.2M 351
2024
Q1
$14.2M Sell
34,007
-2,120
-6% -$886K 1% 17
2023
Q4
$14.7M Sell
36,127
-16,729
-32% -$6.81M 1.97% 12
2023
Q3
$18.4M Sell
52,856
-4,988
-9% -$1.73M 2.97% 4
2023
Q2
$20.4M Buy
57,844
+10,359
+22% +$3.65M 2.89% 7
2023
Q1
$15M Buy
47,485
+44,951
+1,774% +$14.2M 1.31% 23
2022
Q4
$732K Buy
2,534
+1,192
+89% +$344K 0.06% 217
2022
Q3
$389K Sell
1,342
-1,352
-50% -$392K 0.03% 209
2022
Q2
$759K Buy
+2,694
New +$759K 0.06% 176
2022
Q1
Sell
-2,229
Closed -$489K 390
2021
Q4
$489K Buy
+2,229
New +$489K 0.03% 242
2021
Q3
Sell
-1,395
Closed -$281K 471
2021
Q2
$281K Sell
1,395
-267
-16% -$53.8K 0.01% 437
2021
Q1
$357K Buy
+1,662
New +$357K 0.02% 286
2020
Q4
Sell
-978
Closed -$266K 345
2020
Q3
$266K Buy
+978
New +$266K 0.03% 315
2020
Q2
Sell
-1,058
Closed -$252K 325
2020
Q1
$252K Hold
1,058
0.03% 300
2019
Q4
$232K Buy
+1,058
New +$232K 0.02% 333
2016
Q2
Sell
-1,543
Closed -$123K 431
2016
Q1
$123K Hold
1,543
0.01% 321
2015
Q4
$196K Buy
+1,543
New +$196K 0.02% 267
2015
Q3
Sell
-1,683
Closed -$208K 410
2015
Q2
$208K Sell
1,683
-897
-35% -$111K 0.02% 412
2015
Q1
$305K Buy
2,580
+804
+45% +$95K 0.03% 323
2014
Q4
$212K Sell
1,776
-22,142
-93% -$2.64M 0.02% 383
2014
Q3
$2.7M Buy
23,918
+21,358
+834% +$2.41M 0.07% 299
2014
Q2
$241K Buy
+2,560
New +$241K 0.03% 340